tiprankstipranks
Fresenius Medical Care AG & Co. KGaA (MX:FMEN)
LSE:FMEN
Mexico Market
FMEN
Fresenius Medical Care AG & Co. KGaA
RESEARCH TOOLSreports

Fresenius Medical Care AG & Co. KGaA (FMEN) Ratios

― Followers

Fresenius Medical Care AG & Co. KGaA Ratios

MX:FMEN's free cash flow for Q2 2026 was €0.27. For the 2026 fiscal year, MX:FMEN's free cash flow was decreased by € and operating cash flow was €0.11. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Dec 24Dec 23Dec 22
Liquidity Ratios
Current Ratio
 1.07 1.26 1.40 1.42 1.27
Quick Ratio
 0.75 0.92 1.03 1.07 0.91
Cash Ratio
 0.15 0.26 0.20 0.23 0.20
Solvency Ratio
 0.13 0.15 0.13 0.11 0.12
Operating Cash Flow Ratio
 0.39 0.43 0.42 0.43 0.34
Short-Term Operating Cash Flow Coverage
 1.63 1.66 4.13 2.78 1.59
Net Current Asset Value
€ -10.07B€ -8.82B€ -9.88B€ -10.40B€ -12.10B
Leverage Ratios
Debt-to-Assets Ratio
 0.35 0.35 0.33 0.36 0.37
Debt-to-Equity Ratio
 0.87 0.81 0.75 0.88 0.86
Debt-to-Capital Ratio
 0.47 0.45 0.43 0.47 0.46
Long-Term Debt-to-Capital Ratio
 0.32 0.30 0.30 0.34 0.32
Financial Leverage Ratio
 2.49 2.33 2.30 2.49 2.31
Debt Service Coverage Ratio
 1.51 1.51 2.94 1.92 1.68
Interest Coverage Ratio
 5.42 4.74 3.42 3.22 4.27
Debt to Market Cap
 0.71 0.62 0.53 0.71 0.95
Interest Debt Per Share
 42.27 38.40 38.81 42.52 46.28
Net Debt to EBITDA
 2.81 2.76 3.07 3.63 3.71
Profitability Margins
Gross Profit Margin
26.36%25.62%24.60%25.32%27.37%
EBIT Margin
10.82%9.66%7.57%6.79%8.14%
EBITDA Margin
18.15%17.01%16.58%15.08%16.60%
Operating Profit Margin
10.69%9.31%7.20%7.04%7.93%
Pretax Profit Margin
7.73%7.70%5.47%5.31%6.29%
Net Profit Margin
4.83%4.98%2.78%2.57%3.47%
Continuous Operations Profit Margin
6.11%6.07%3.83%3.14%4.61%
Net Income Per EBT
62.45%64.68%50.89%48.30%55.23%
EBT Per EBIT
72.30%82.77%75.91%75.43%79.28%
Return on Assets (ROA)
3.00%3.15%1.60%1.47%1.88%
Return on Equity (ROE)
7.21%7.35%3.69%3.66%4.36%
Return on Capital Employed (ROCE)
8.61%7.38%4.99%4.92%5.25%
Return on Invested Capital (ROIC)
6.21%5.34%3.35%3.30%3.60%
Return on Tangible Assets
5.84%6.05%3.16%2.78%3.65%
Earnings Yield
8.75%8.24%4.15%4.48%7.51%
Efficiency Ratios
Receivables Turnover
 5.61 6.25 4.93 4.79 5.21
Payables Turnover
 16.04 19.78 14.81 19.06 15.24
Inventory Turnover
 6.14 6.82 7.05 6.67 6.32
Fixed Asset Turnover
 3.02 3.02 2.66 2.61 4.63
Asset Turnover
 0.62 0.63 0.58 0.57 0.54
Working Capital Turnover Ratio
 20.56 10.03 7.97 8.99 15.87
Cash Conversion Cycle
 101.84 93.51 101.14 111.79 103.83
Days of Sales Outstanding
 65.10 58.43 74.01 76.19 69.99
Days of Inventory Outstanding
 59.49 53.53 51.77 54.75 57.78
Days of Payables Outstanding
 22.75 18.45 24.64 19.15 23.95
Operating Cycle
 124.59 111.96 125.79 130.94 127.78
Cash Flow Ratios
Operating Cash Flow Per Share
 10.54 9.21 8.13 8.96 7.39
Free Cash Flow Per Share
 6.65 6.06 5.75 6.63 4.92
CapEx Per Share
 3.90 3.14 2.38 2.33 2.47
Free Cash Flow to Operating Cash Flow
 0.63 0.66 0.71 0.74 0.67
Dividend Paid and CapEx Coverage Ratio
 2.71 2.00 2.28 2.59 1.94
Capital Expenditure Coverage Ratio
 2.71 2.93 3.41 3.84 2.99
Operating Cash Flow Coverage Ratio
 0.26 0.25 0.22 0.22 0.16
Operating Cash Flow to Sales Ratio
 0.15 0.14 0.12 0.14 0.11
Free Cash Flow Yield
16.80%14.88%13.02%17.46%16.10%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 12.02 12.13 24.13 22.32 13.31
Price-to-Sales (P/S) Ratio
 0.55 0.60 0.67 0.57 0.46
Price-to-Book (P/B) Ratio
 0.85 0.89 0.89 0.82 0.58
Price-to-Free Cash Flow (P/FCF) Ratio
 5.95 6.72 7.68 5.73 6.21
Price-to-Operating Cash Flow Ratio
 3.79 4.43 5.43 4.24 4.14
Price-to-Earnings Growth (PEG) Ratio
 0.25 0.15 3.16 -0.86 -0.44
Price-to-Fair Value
 0.85 0.89 0.89 0.82 0.58
Enterprise Value Multiple
 5.82 6.31 7.11 7.43 6.49
Enterprise Value
 20.53B 21.07B 22.79B 21.78B 20.90B
EV to EBITDA
 5.82 6.31 7.11 7.43 6.49
EV to Sales
 1.06 1.07 1.18 1.12 1.08
EV to Free Cash Flow
 11.50 11.93 13.51 11.21 14.48
EV to Operating Cash Flow
 7.25 7.86 9.55 8.29 9.64
Tangible Book Value Per Share
 -6.40 -1.86 -2.63 -4.04 -6.35
Shareholders’ Equity Per Share
 46.78 45.71 49.68 46.42 52.68
Tax and Other Ratios
Effective Tax Rate
 0.21 0.21 0.30 0.29 0.27
Revenue Per Share
 72.37 67.41 65.90 66.30 66.15
Net Income Per Share
 3.49 3.36 1.83 1.70 2.30
Tax Burden
 0.62 0.65 0.51 0.48 0.55
Interest Burden
 0.71 0.80 0.72 0.78 0.77
Research & Development to Revenue
 <0.01 <0.01 <0.01 0.01 0.01
SG&A to Revenue
 0.15 0.15 0.16 0.12 0.12
Stock-Based Compensation to Revenue
 0.00 0.00 0.00 <0.01 >-0.01
Income Quality
 2.67 2.74 3.22 3.59 3.22
Currency in EUR